Unique and Independent Roles for MLL in Adult Hematopoietic Stem Cells and Progenitors

Overview

Journal Cell Stem Cell

Publisher Cell Press

Specialty Cell Biology

Date 2008 Mar 29

PMID 18371366

Citations 177

Authors

Craig D Jude

Leslie Climer

Diyong Xu

Erika Artinger

Jill K Fisher

Patricia Ernst

Affiliations

Soon will be listed here.

Abstract

The Mixed Lineage Leukemia (MLL) gene is essential for embryonic hematopoietic stem cell (HSC) development, but its role during adult hematopoiesis is unknown. Using an inducible knockout model, we demonstrate that Mll is essential for the maintenance of adult HSCs and progenitors, with fatal bone marrow failure occurring within 3 weeks of Mll deletion. Mll-deficient cells are selectively lost from mixed bone marrow chimeras, demonstrating their failure to self-renew even in an intact bone marrow environment. Surprisingly, HSCs lacking Mll exhibit ectopic cell-cycle entry, resulting in the depletion of quiescent HSCs. In contrast, Mll deletion in myelo-erythroid progenitors results in reduced proliferation and reduced response to cytokine-induced cell-cycle entry. Committed lymphoid and myeloid cells no longer require Mll, defining the early multipotent stages of hematopoiesis as Mll dependent. These studies demonstrate that Mll plays selective and independent roles within the hematopoietic system, maintaining quiescence in HSCs and promoting proliferation in progenitors.

Citing Articles

The epigenetic state of the cell of origin defines mechanisms of leukemogenesis.

Li Z, Fierstein S, Tanaka-Yano M, Frenis K, Chen C, Wang D Leukemia. 2024; 39(1):87-97.

PMID: 39354203 DOI: 10.1038/s41375-024-02428-y.

Menin in Cancer.

Majer A, Hua X, Katona B Genes (Basel). 2024; 15(9).

PMID: 39336822 PMC: 11431421. DOI: 10.3390/genes15091231.

Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis.

Wallace L, Obeng E Front Mol Biosci. 2023; 10:1273046.

PMID: 38028538 PMC: 10644717. DOI: 10.3389/fmolb.2023.1273046.

Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia.

Zhang Y, Schonberger K, Cabezas-Wallscheid N EMBO J. 2023; 42(24):e112348.

PMID: 38010205 PMC: 10711668. DOI: 10.15252/embj.2022112348.

RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription.

Blatter M, Meylan C, Clery A, Giambruno R, Nikolaev Y, Heidecker M Sci Adv. 2023; 9(16):eadf5330.

PMID: 37075125 PMC: 10115415. DOI: 10.1126/sciadv.adf5330.

References

Ernst P, Fisher J, Avery W, Wade S, Foy D, Korsmeyer S . Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell. 2004; 6(3):437-43. DOI: 10.1016/s1534-5807(04)00061-9. View

Djabali M, Selleri L, PARRY P, Bower M, Young B, Evans G . A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet. 1993; 4(4):431. DOI: 10.1038/ng0893-431. View

Ruault M, Brun M, Ventura M, Roizes G, De Sario A . MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia. Gene. 2002; 284(1-2):73-81. DOI: 10.1016/s0378-1119(02)00392-x. View

Xia Z, Popovic R, Chen J, Theisler C, Stuart T, Santillan D . The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression. Proc Natl Acad Sci U S A. 2005; 102(39):14028-33. PMC: 1236570. DOI: 10.1073/pnas.0506464102. View

Lawrence H, Christensen J, Fong S, Hu Y, Weissman I, Sauvageau G . Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 2005; 106(12):3988-94. PMC: 1895111. DOI: 10.1182/blood-2005-05-2003. View

Kuhn R, Schwenk F, Aguet M, Rajewsky K . Inducible gene targeting in mice. Science. 1995; 269(5229):1427-9. DOI: 10.1126/science.7660125. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Armstrong S, Staunton J, Silverman L, Pieters R, den Boer M, Minden M . MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2001; 30(1):41-7. DOI: 10.1038/ng765. View

Yokoyama A, Somervaille T, Smith K, Rozenblatt-Rosen O, Meyerson M, Cleary M . The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005; 123(2):207-18. DOI: 10.1016/j.cell.2005.09.025. View

10.

Ernst P, Mabon M, Davidson A, Zon L, Korsmeyer S . An Mll-dependent Hox program drives hematopoietic progenitor expansion. Curr Biol. 2004; 14(22):2063-9. DOI: 10.1016/j.cub.2004.11.012. View

11.

Opferman J, Iwasaki H, Ong C, Suh H, Mizuno S, Akashi K . Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science. 2005; 307(5712):1101-4. DOI: 10.1126/science.1106114. View

12.

Bijl J, Thompson A, Ramirez-Solis R, Krosl J, Grier D, Lawrence H . Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood. 2005; 108(1):116-22. PMC: 1895826. DOI: 10.1182/blood-2005-06-2245. View

13.

Yagi H, Deguchi K, Aono A, Tani Y, Kishimoto T, Komori T . Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood. 1998; 92(1):108-17. View

14.

Biondi A, Cimino G, Pieters R, Pui C . Biological and therapeutic aspects of infant leukemia. Blood. 2000; 96(1):24-33. View

15.

Ayton P, Cleary M . Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001; 20(40):5695-707. DOI: 10.1038/sj.onc.1204639. View

16.

Yu B, Hess J, Horning S, Brown G, Korsmeyer S . Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 1995; 378(6556):505-8. DOI: 10.1038/378505a0. View

17.

Ayton P, Cleary M . Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 2003; 17(18):2298-307. PMC: 196466. DOI: 10.1101/gad.1111603. View

18.

Yokoyama A, Kitabayashi I, Ayton P, Cleary M, Ohki M . Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood. 2002; 100(10):3710-8. DOI: 10.1182/blood-2002-04-1015. View

19.

Guenther M, Jenner R, Chevalier B, Nakamura T, Croce C, Canaani E . Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A. 2005; 102(24):8603-8. PMC: 1150839. DOI: 10.1073/pnas.0503072102. View

20.

Ayton P, Sneddon S, Palmer D, Rosewell I, Owen M, Young B . Truncation of the Mll gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos. Genesis. 2001; 30(4):201-12. DOI: 10.1002/gene.1066. View